Transvaginal mesh is implanted to permanently fix pelvic organ prolapsed) and stress urinary incontinence (SUI) in women. The device is first launched in 1996 and made by various manufacturers that use a range of synthetic or biological materials in their devices, which are designed for permanent implantation. However TVM has been linked to serious health complications that can often require painful and invasive revision surgeries to correct. Around 100,000 federal lawsuits have been filed against seven manufacturers of mesh products in the U.S court. Though there are many manufacturers of transvaginal mesh devices, thus far companies named in current lawsuits include such notables as: American Medical Systems (AMS), a subsidiary of Endo, C.R. Bard, Cook Medical Inc., Boston Scientific, Coloplast Corp and Neomedic.
The Women throughout the United States suffering from numbers of life-threatening complications of Transvaginal mesh Include pain during intercourse, Mesh erosion into the vagina, Perforated bladder, perforated bowel or perforated blood vessels, Organ injuries, Multiple occurrences of pelvic organ prolapse and Urinary tract problems. The manufacturers accused of poorly testing of device and inadequate research to find out the risks of mesh products used for the treatment of female pelvic floor disorders and faces thousand of lawsuits which involves similar allegations that the manufacturers have not disclose and mispresented the severe risks associated with transvaginal mesh implant and falsely marketing the device without adequate warning of it adverse effects.
The U.S. Food and Drug Administration this year re-labeled the products high risk instead of moderate and announced new federal scrutiny for the company. The reclassification of the mesh is a confirmation of the inherent danger of these products. The FDA ordered the manufacturers to endure a premarket approval (PMA) application to support the safety and effectiveness of surgical mesh for the treatment of POP. The FDA’s Center for Devices and Radiological Health deputy director of science and chief scientist William Maisel states that these stronger clinical requirements will help to address the severe risks associated with surgical mesh for repair of pelvic organ prolapse. The agency previously reported in 2008 that adverse event causes by surgical mesh are rare but in 2011 the FDA updated its statement and warned patients and doctors that the transvaginal placement of the surgical mesh may put women at a greater risk for POP mesh complications than other surgical options and it is not rare.
Numbers of women who take their fight against manufacturers to court after suffering with serious complications caused due to the use of Transvaginal Mesh products are winning legal claims by getting compensation. If you or somebody you know was injured or suffered complications or death from Transvaginal mesh may be entitled to compensation for medical expenses, pain and suffering, lost wages, and other damages. Contact Drugsclaim.com for a free case consultation. All cases are pursued on a contingency fee basis there are never any out-of-pocket costs to hire our attorneys unless we win your case. The Medical Device Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs Lawsuits.